- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.85 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x AOQ: 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione(Non-covalent)
AOQ.3: 20 residues within 4Å:- Chain A: L.137, M.140, F.144, Y.147, M.154, W.157, G.158, V.161, I.162, L.165, I.292, P.294, F.298, F.301, Y.302, L.305, M.336, F.337, I.340
- Chain F: H.152
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:M.140, A:I.162, A:I.292, A:P.294, A:F.298, A:F.298
AOQ.11: 18 residues within 4Å:- Chain C: C.151, H.152
- Chain D: L.137, M.140, F.144, M.154, G.158, V.161, I.162, L.165, I.292, P.294, F.298, F.301, Y.302, L.305, M.336, F.337
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:M.140, D:V.161, D:I.162, D:I.292, D:P.294, D:F.298, D:F.301, D:Y.302, D:F.337
- 2 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
6PE.4: 13 residues within 4Å:- Chain A: N.42, W.43, M.44, L.110, F.113, R.114, Y.117, Y.118, P.224, R.358, F.367, W.368, A.371
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.113, A:F.113, A:F.367
- Hydrogen bonds: A:N.42, A:Y.117, A:Y.117, A:Y.118
- Salt bridges: A:R.358
6PE.12: 12 residues within 4Å:- Chain D: N.42, M.44, Y.109, L.110, F.113, R.114, Y.117, Y.118, R.358, F.367, W.368, A.371
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:L.110
- Hydrogen bonds: D:N.42, D:Y.117, D:Y.117, D:Y.118
- Salt bridges: D:R.358
- 2 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
BOG.5: 17 residues within 4Å:- Chain A: V.262, A.265, I.266, F.269, M.270
- Chain B: F.13, E.14, G.15, P.16, Q.120, L.121, F.122, N.123, G.124, I.125, R.226, K.227
7 PLIP interactions:5 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:V.262, A:A.265, A:I.266, A:F.269
- Hydrogen bonds: A:F.269, B:G.15, B:K.227
BOG.13: 15 residues within 4Å:- Chain D: V.262, A.265, I.266, F.269, M.270
- Chain E: E.14, G.15, P.16, Q.120, L.121, N.123, G.124, I.125, R.226, K.227
9 PLIP interactions:4 interactions with chain D, 5 interactions with chain E- Hydrophobic interactions: D:V.262, D:A.265, D:I.266, D:F.269
- Hydrogen bonds: E:G.15, E:Q.120, E:G.124, E:R.226, E:K.227
- 2 x HEC: HEME C(Covalent)
HEC.6: 27 residues within 4Å:- Chain B: V.31, V.35, C.36, A.38, C.39, H.40, L.94, N.96, A.97, P.98, L.100, M.103, R.107, Y.130, I.131, V.134, L.135, F.160, N.162, I.183, A.184, M.185, P.186, P.188, L.189, V.211, L.215
17 PLIP interactions:17 interactions with chain B,- Hydrophobic interactions: B:P.98, B:L.100, B:L.135, B:F.160, B:I.183, B:M.185, B:P.186, B:P.188, B:L.215
- Hydrogen bonds: B:Y.130, B:Y.130, B:A.184
- Salt bridges: B:R.107
- pi-Stacking: B:H.40, B:H.40
- pi-Cation interactions: B:H.40
- Metal complexes: B:H.40
HEC.14: 26 residues within 4Å:- Chain E: V.31, V.35, C.36, A.38, C.39, H.40, L.94, N.96, A.97, P.98, L.100, M.103, R.107, Y.130, I.131, V.134, L.135, F.160, I.183, A.184, M.185, P.186, P.188, L.189, V.211, L.215
17 PLIP interactions:17 interactions with chain E,- Hydrophobic interactions: E:L.94, E:P.98, E:L.100, E:L.135, E:I.183, E:A.184, E:M.185, E:P.188, E:L.215
- Hydrogen bonds: E:Y.130, E:Y.130, E:A.184
- Salt bridges: E:R.107
- pi-Stacking: E:H.40, E:H.40
- pi-Cation interactions: E:H.40
- Metal complexes: E:H.40
- 2 x SR: STRONTIUM ION(Non-functional Binders)
SR.7: 5 residues within 4Å:- Chain B: D.8, V.9, P.10, E.14, E.129
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.8, B:V.9, B:E.14, B:E.129, B:E.129
SR.15: 7 residues within 4Å:- Chain E: D.8, V.9, P.10, F.11, E.14, F.110, E.129
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.8, E:V.9, E:E.14, E:E.14, E:E.129
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
FES.8: 11 residues within 4Å:- Chain C: C.129, H.131, L.132, G.133, C.134, C.149, C.151, H.152, G.153, S.154, P.166
4 PLIP interactions:4 interactions with chain C,- Metal complexes: C:C.129, C:H.131, C:C.149, C:H.152
FES.16: 11 residues within 4Å:- Chain F: C.129, H.131, L.132, G.133, C.134, C.149, C.151, H.152, G.153, S.154, P.166
4 PLIP interactions:4 interactions with chain F,- Metal complexes: F:C.129, F:H.131, F:C.149, F:H.152
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Esser, L. et al., Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone. To Be Published
- Release Date
- 2023-01-18
- Peptides
- Cytochrome b: AD
Cytochrome c1: BE
Ubiquinol-cytochrome c reductase iron-sulfur subunit: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
KD
OB
LE
PC
MF
Q - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.85 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x AOQ: 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione(Non-covalent)
- 2 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 2 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
- 2 x HEC: HEME C(Covalent)
- 2 x SR: STRONTIUM ION(Non-functional Binders)
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Esser, L. et al., Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone. To Be Published
- Release Date
- 2023-01-18
- Peptides
- Cytochrome b: AD
Cytochrome c1: BE
Ubiquinol-cytochrome c reductase iron-sulfur subunit: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
KD
OB
LE
PC
MF
Q - Membrane
-
We predict this structure to be a membrane protein.